Future Oncology, Volume 15, Issue 34 (2019)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Future Oncology, Volume 15, Issue 34 (2019)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Volume 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Is there a Role for Maintenance Therapy After Platinum Chemotherapy in Bladder Cancer in the Era of Immune Therapy?
Elie Rassy, Tarek Assi & Joseph Kattan
Pages: 3877-3879
Published online: 15 Nov 2019
AbstractforIs there a Role for Maintenance Therapy After Platinum Chemotherapy in Bladder Cancer in the Era of Immune Therapy? | Full Text | References | PDF (1.2 MB) | EPUB
  • 1425 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Editorial
Salvage Therapy for Relapsed Testicular Cancer: A Need for Consensus
Vaibhav Agrawal & Nabil Adra
Pages: 3881-3884
Published online: 12 Nov 2019
AbstractforSalvage Therapy for Relapsed Testicular Cancer: A Need for Consensus | Full Text | References | PDF (1.2 MB) | EPUB
  • 66 Views
  • 0 CrossRef citations
  • 0Altmetric

Drug Evaluation

Review Article
Quizartinib in the Treatment of FLT3-Internal-Tandem Duplication-Positive Acute Myeloid Leukemia
Shilpa Paul, Adam J DiPippo, Farhad Ravandi & Tapan M Kadia
Pages: 3885-3894
Published online: 27 Sep 2019
AbstractforQuizartinib in the Treatment of FLT3-Internal-Tandem Duplication-Positive Acute Myeloid Leukemia | Full Text | References | PDF (1.3 MB) | EPUB
  • 241 Views
  • 2 CrossRef citations
  • 0Altmetric

Short Communication

Brief Report
Patient Preferences for Attributes of Tyrosine Kinase Inhibitor Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer
John FP Bridges, Marie de la Cruz, Melissa Pavilack, Emuella Flood, Ellen M Janssen, Nabil Chehab & Ancilla W Fernandes
Pages: 3895-3907
Published online: 17 Oct 2019
AbstractforPatient Preferences for Attributes of Tyrosine Kinase Inhibitor Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer | Full Text | References | PDF (1.4 MB) | EPUB
  • 315 Views
  • 10 CrossRef citations
  • 0Altmetric

Perspective

Review Article
Potential Interaction of Inflammatory Hyperemia and Hyperphosphatemia in Tumorigenesis
Ronald B Brown
Pages: 3909-3916
Published online: 15 Nov 2019
AbstractforPotential Interaction of Inflammatory Hyperemia and Hyperphosphatemia in Tumorigenesis | Full Text | References | PDF (1.5 MB) | EPUB
  • 180 Views
  • 4 CrossRef citations
  • 0Altmetric

Research Article

Article
Differential Network Analysis Depicts Regulatory Mechanisms for Hepatocellular Carcinoma from Diverse Backgrounds
Min-Cheng Yu, Ji-Xiang Liu, Xiao-Lu Ma, Bo Hu, Pei-Yao Fu, Hai-Xiang Sun, Wei-Guo Tang, Zhang-Fu Yang, Shuang-Jian Qiu, Jian Zhou, Jia Fan & Yang Xu
Pages: 3917-3934
Published online: 15 Nov 2019
AbstractforDifferential Network Analysis Depicts Regulatory Mechanisms for Hepatocellular Carcinoma from Diverse Backgrounds | Full Text | References | PDF (7.3 MB) | EPUB | Supplemental
  • 144 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Observational Study of Clinical Outcomes of Eribulin Mesylate in Metastatic Breast Cancer After Cyclin-Dependent Kinase 4/6 Inhibitor Therapy
Sarah S Mougalian, Bruce A Feinberg, Edward Wang, Karenza Alexis, Debanjana Chatterjee, Russell L Knoth, Damion Nero, Talia Miller, Djibril Liassou & Jonathan K Kish
Pages: 3935-3944
Published online: 29 Oct 2019
AbstractforObservational Study of Clinical Outcomes of Eribulin Mesylate in Metastatic Breast Cancer After Cyclin-Dependent Kinase 4/6 Inhibitor Therapy | Full Text | References | PDF (1.4 MB) | EPUB
  • 4811 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Article
Incidence and Survival Trends for Appendiceal Mucinous Adenocarcinoma: An Analysis of 3237 Patients in the Surveillance, Epidemiology, and End Results Database
Qian Yan, Wenjiang Zheng, Huiyan Luo, Boqing Wang, Xiaoying Zhang & Xiongwen Wang
Pages: 3945-3961
Published online: 20 Nov 2019
AbstractforIncidence and Survival Trends for Appendiceal Mucinous Adenocarcinoma: An Analysis of 3237 Patients in the Surveillance, Epidemiology, and End Results Database | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 175 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The Effect of Marital Status on Endometrial Cancer-Related Diagnosis and Prognosis: A Surveillance Epidemiology and End Results Database Analysis
Jia Dong, Qinjin Dai & Fan Zhang
Pages: 3963-3976
Published online: 20 Nov 2019
AbstractforThe Effect of Marital Status on Endometrial Cancer-Related Diagnosis and Prognosis: A Surveillance Epidemiology and End Results Database Analysis | Full Text | References | PDF (1.4 MB) | EPUB
  • 190 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Survival Outcomes of Mucosal Melanoma in the USA
Ali Al-Haseni, Abby Vrable, Muhammad Mustafa Qureshi, Stephanie Mathews, Samara Pollock, Minh-Tam Truong & Debjani Sahni
Pages: 3977-3986
Published online: 14 Nov 2019
AbstractforSurvival Outcomes of Mucosal Melanoma in the USA | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 179 Views
  • 11 CrossRef citations
  • 0Altmetric

Systematic Review

Review Article
Augmenting the Randomized Controlled Trial with Real-World Data to Aid Clinical Decision Making in Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Michael Moran, Dana Nickens, Katherine Adcock, Meg Bennetts, Natalie Charnley & Kate Fife
Pages: 3987-4001
Published online: 18 Oct 2019
AbstractforAugmenting the Randomized Controlled Trial with Real-World Data to Aid Clinical Decision Making in Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis | Full Text | References | PDF (1.6 MB) | EPUB
  • 2815 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
Jingchuan Zhang et al.
Rapid Communication | Published online: 9 Aug 2024
Open Access
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Isabel Blancas et al.
Rapid Communication | Published online: 8 Aug 2024
Open Access
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding et al.
Plain Language Summary of Publication | Published online: 8 Aug 2024
Open Access
Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Jesús San-Miguel et al.
Plain Language Summary of Publication | Published online: 7 Aug 2024
Open Access
View all latest articles